The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
I would be not be surprised if there was, in due course, more than one offer, ie a contested offer. But would much prefer to see this develop into a major winner over several years.
Genghis, I agree. i have been here since 2015, and original purchases were ~65-75p. The low levels seen recently resulted from a forced seller - Jupiter - and I think the recent 50% rise just reflects a return to a sensible pre-FDA 'holding' price. I guess it will fluctuate perhaps 60-90p before the big day, when 150-200p would seem right for starters. I still think it is a buy at present prices.
But I cannot say his spin on the advantages of a fundraise limited to the White family and chums in the city cut much ice with me. Just a nice way of handing out an immediate 50+% profit, while diluting my shareholding.
Or even employ someone who can write English. It used to be a requirement of employment for many firms, but this is no longer the case. ditto BBC, ditto many newspapers from The Times down to the gutter press. Now I feel better.
I note AN said in his presentation that approval would be towards end of Q2 2021. i thought end Q1 / early Q2 was on hte cards, but seems not to be the case
3 very large sells yesterday; is someone still unloading apart from Jupiter who are said to have finished?
I hope you get all the extras, including personalised colour, top end leather seats etc,. Have no worries, 2021 is the year for Angle, and your dream may well come true.
Happy new year to all.
Malachi
c
If the ovarian study is successful - which given previous publications - seems likely, is there any reason why AGL should not submit an additional application straight away, rather than waiting for the outcome (successful) of the FDA breast application?
Anyone leaving AGL now needs help from the nice men in white coats - IMVHO etc,.
Or have various big sellers finally cleared?
Does anyone know what happens to IHT on an AIM stock - carried for > 2 yr plus - that then moves to the main market. It is not inconceivable with the likes of AFC when it is a multibillion £ outfit? Is the IHT exemption lost?